Cargando…

Utility of High-Sensitivity Modified Glasgow Prognostic Score in Cancer Prognosis: A Systemic Review and Meta-Analysis

The suitability of the high-sensitivity modified Glasgow Prognostic Score (HS-mGPS) in cancer patients remains unknown. We performed a systematic database search from 1 January 2010 to 30 September 2022, in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Tsung-Hsien, Tsai, Yao-Te, Chen, Kuan-Yin, Yap, Wing-Keen, Luan, Chih-Wei
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9866297/ https://www.ncbi.nlm.nih.gov/pubmed/36674837 http://dx.doi.org/10.3390/ijms24021318

Ejemplares similares

Prognostic Role of High-Sensitivity Modified Glasgow Prognostic Score for Patients With Operated Oral Cavity Cancer: A Retrospective Study
por: Tsai, Yao-Te, et al.
Publicado: (2022)

Utility of the High-Sensitivity Modified Glasgow Prognostic Scores for Oropharyngeal Carcinoma
por: Iuchi, Hiroyuki, et al.
Publicado: (2021)

Utility of the Modified and High-Sensitivity Modified Glasgow Prognostic Scores for Hypopharyngeal Squamous Cell Carcinoma
por: Iuchi, Hiroyuki, et al.
Publicado: (2021)

The high-sensitivity modified Glasgow prognostic score is superior to the modified Glasgow prognostic score as a prognostic predictor for head and neck cancer
por: Hanai, Nobuhiro, et al.
Publicado: (2018)

Glasgow prognostic score is a better predictor of the long-term survival in patients with gastric cancer, compared to the modified Glasgow prognostic score or high-sensitivity modified Glasgow prognostic score
por: Hirahara, Noriyuki, et al.
Publicado: (2020)

The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma
por: Tian, Rui, et al.
Publicado: (2016)

Modified Glasgow Prognostic Score is Better for Predicting Oncological Outcome in Patients with Soft Tissue Sarcoma, Compared to High-Sensitivity Modified Glasgow Prognostic Score
por: Nakamura, Tomoki, et al.
Publicado: (2022)

Clinical utility of the modified Glasgow prognostic score in lung cancer: A meta-analysis
por: Jin, Jing, et al.
Publicado: (2017)

Glasgow Prognostic Score and modified Glasgow Prognostic Score and survival in patients with hepatocellular carcinoma: a meta-analysis
por: Lu, Lingling, et al.
Publicado: (2021)

Prognostic Utility of the Modified Glasgow Prognostic Score in Urothelial Carcinoma: Outcomes from a Pooled Analysis
por: Tan, Daqing, et al.
Publicado: (2022)

External validation of the modified Glasgow prognostic score for renal cancer
por: Tai, Caroline G., et al.
Publicado: (2014)

A Meta-Analysis of Glasgow Prognostic Score and Modified Glasgow Prognostic Score as Biomarkers for Predicting Survival Outcome in Renal Cell Carcinoma
por: Tong, Tongyu, et al.
Publicado: (2020)

Lymphocyte to Monocyte Ratio and Modified Glasgow Prognostic Score Predict Prognosis of Lung Adenocarcinoma Without Driver Mutation
por: Minami, Seigo, et al.
Publicado: (2018)

Modified Glasgow prognostic score predicts the prognosis of patients with advanced esophageal squamous cell carcinoma: A propensity score‐matched analysis
por: Cui, Chanjuan, et al.
Publicado: (2022)

The prognostic value of modified Glasgow Prognostic Score in pancreatic cancer: a meta-analysis
por: Zhang, Huan, et al.
Publicado: (2020)

Prognostic Value of High-Sensitivity Modified Glasgow Prognostic Score in Castration-Resistant Prostate Cancer Patients Who Received Docetaxel
por: Ando, Keisuke, et al.
Publicado: (2021)

Prognostic value of preoperative high-sensitivity modified Glasgow prognostic score in advanced colon cancer: a retrospective observational study
por: Kasahara, Kenta, et al.
Publicado: (2022)

Prognostic Roles of Glucose to Lymphocyte Ratio and Modified Glasgow Prognosis Score in Patients With Non-small Cell Lung Cancer
por: Yang, Ming, et al.
Publicado: (2022)

Pretreatment Modified Glasgow Prognostic Score for Predicting Prognosis and Survival in Elderly Patients with Gastric Cancer Treated with Perioperative FLOT
por: Melekoglu, Ebru, et al.
Publicado: (2023)

Prognostic Value of the Modified Glasgow Prognostic Score in Patients Undergoing Radical Surgery for Hepatocellular Carcinoma
por: Ni, Xiao-Chun, et al.
Publicado: (2015)

The modified glasgow prognostic score is an independent prognostic indicator in neoadjuvantly treated adenocarcinoma of the esophagogastric junction
por: Jomrich, Gerd, et al.
Publicado: (2018)

Prognostic Significance of the Modified Glasgow Prognostic Score in Patients With Pancreatic Cancer: A Meta-Analysis
por: Fu, Wen, et al.
Publicado: (2020)

Pretreatment prognostic nutritional index as a prognostic marker in head and neck cancer: a systematic review and meta-analysis
por: Luan, Chih-Wei, et al.
Publicado: (2021)

A comprehensive analysis of Glasgow Prognostic Score (GPS)/the modified Glasgow Prognostic Score (mGPS) on immune checkpoint inhibitor efficacy among patients with advanced cancer
por: Zhang, Yongchao, et al.
Publicado: (2022)

The modified Glasgow prognostic score in Crohn’s disease—does it predict short-term outcome?
por: Argeny, Stanislaus, et al.
Publicado: (2018)

Glasgow prognostic score is an independent marker for poor prognosis with all cases of epithelial ovarian cancer
por: Omichi, Chiaki, et al.
Publicado: (2016)

Prognostic value of pretreatment modified Glasgow Prognostic Score in small cell lung cancer: A meta-analysis
por: Xie, Yulian, et al.
Publicado: (2023)

High-sensitivity modified Glasgow prognostic score (HS-mGPS) Is superior to the mGPS in esophageal cancer patients treated with chemoradiotherapy
por: Chen, Peng, et al.
Publicado: (2017)

Significance of the Glasgow Prognostic Score in Predicting the Postoperative Outcome of Patients with Stage III Gastric Cancer
por: Hsueh, Shun-Wen, et al.
Publicado: (2019)

The Modified Glasgow Prognostic Score as a Predictor of Survival After Hepatectomy for Colorectal Liver Metastases
por: Nakagawa, Kazuya, et al.
Publicado: (2014)

Biliary drainage improves the predictive value of modified Glasgow Prognostic Scores in inoperable pancreatic cancer
por: Iino, Chikara, et al.
Publicado: (2017)

The inflammation‐based modified Glasgow prognostic score is associated with survival in stable heart failure patients
por: Cho, Anna, et al.
Publicado: (2020)

Prediction of Treatment Response and Survival with Chemotherapy for Metastatic Penile Cancer by the Modified Glasgow Prognostic Score
por: Draeger, Desiree-Louise, et al.
Publicado: (2023)

Clinical utility of the Glasgow Prognostic Score in patients undergoing curative nephrectomy for renal clear cell cancer: basis of new prognostic scoring systems
por: Lamb, G W A, et al.
Publicado: (2012)

Modified Glasgow prognostic score as a prognostic factor for renal cell carcinomas: a systematic review and meta-analysis
por: Hu, Xu, et al.
Publicado: (2019)

Prognostic and clinical significance of modified glasgow prognostic score in pancreatic cancer: a meta-analysis of 4,629 patients
por: Wu, Dongdong, et al.
Publicado: (2021)

Glasgow prognostic score predicts prognosis of non-small cell lung cancer: a meta-analysis
por: Zhu, Lucheng, et al.
Publicado: (2016)

Glasgow prognostic score after concurrent chemoradiotherapy is a prognostic factor in advanced head and neck cancer
por: Chang, Pei-Hung, et al.
Publicado: (2017)

The Glasgow Prognostic Score, an inflammation based prognostic score, predicts survival in patients with hepatocellular carcinoma
por: Kinoshita, Akiyoshi, et al.
Publicado: (2013)

Inflammation-based score (Glasgow prognostic score) as an independent prognostic factor in colorectal cancer patients
por: Choi, Kyeong Woon, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_vtf6aiaabjc9en0tuu0uihtiaa